Cohen Klingenstein LLC Organon & Co. Transaction History

Cohen Klingenstein LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 12, 2024	SELL	$10.95 - $17.32 $28,864 - $45,655	-2,636 Reduced 20.18%	10,429 $150,000
Q3 2023 Oct 13, 2023	SELL	$16.59 - $23.77 $31,919 - $45,733	-1,924 Reduced 12.84%	13,065 $226,000
Q4 2022 Jan 13, 2023	SELL	$23.31 - $28.61 $7,179 - $8,811	-308 Reduced 2.01%	14,989 $0
Q3 2022 Oct 12, 2022	SELL	$23.4 - $34.25 $9,360 - $13,700	-400 Reduced 2.55%	15,297 $358,000
Q4 2021 Jan 14, 2022	SELL	$28.67 - $37.13 $66,399 - $85,993	-2,316 Reduced 12.86%	15,697 $478,000
Q3 2021 Oct 15, 2021	SELL	$28.63 - $35.64 $70,630 - $87,923	-2,467 Reduced 12.05%	18,013 $591,000
Q2 2021 Jul 16, 2021	BUY	$28.45 - $38.0 $582,656 - $778,240	20,480 New	20,480 $620,000

791

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.75B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Cohen Klingenstein LLC, based on Form 13F filings with the SEC.

Stay updated on Cohen Klingenstein LLC with notifications on news.